Skip to main content
Log in

Diabetic Foot Ulcers

Practical Treatment Recommendations

  • Therapy In Practice
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

When treating diabetic foot ulcers it is important to be aware of the natural history of the diabetic foot, which can be divided into five stages: stage 1, a normal foot; stage 2, a high risk foot; stage 3, an ulcerated foot; stage 4, an infected foot; and stage 5, a necrotic foot. This covers the entire spectrum of foot disease but emphasises the development of the foot ulcer as a pivotal event in stage 3, which demands urgent and aggressive management. Diabetic foot care in all stages needs multidisciplinary management to control mechanical, wound, microbiological, vascular, metabolic and educational aspects. Achieving good metabolic control of blood glucose, lipids and blood pressure is important in each stage, as is education to teach proper foot care appropriate for each stage.

Ideally, it is important to prevent the development of ulcers in stages 1 and 2. In stage 1, the normal foot, it is important to encourage the use of suitable footwear, and to educate the patient to promote healthy foot care and footwear habits. In stage 2, the foot has developed one or more of the following risk factors for ulceration: neuropathy, ischaemia, deformity, swelling and callus. The majority of deformities can be accommodated in special footwear and as callus is an important precursor of ulceration it should be treated aggressively, especially in the neuropathic foot. In stage 3, ulcers can be divided into two distinct entities: those in the neuropathic foot and those in the neuroischaemic foot. In the neuropathic foot, ulcers commonly develop on the plantar surface of the foot and the toes, and are associated with neglected callus and high plantar pressures. In the neuroischaemic foot, ulcers are commonly seen around the edges of the foot, including the apices of the toes and back of the heel, and are associated with trauma or wearing unsuitable shoes. Ulcers in stage 3 need relief of pressure (mechanical control), sharp debridement and dressings (wound control), and neuroischaemic foot ulcers may need vascular intervention (vascular control). In stage 4, microbiological control is crucial and severe infections need intravenous antibacterial therapy, and urgent assessment of the need for surgical drainage and debridement. Without urgent treatment, severe infections will progress to necrosis. In stage 5, necrosis can be divided into wet and dry necrosis. Wet necrosis in neuropathic feet requires intravenous antibacterials and surgical debridement, and wet necrosis in neuroischaemic feet also needs vascular reconstruction. Aggressive management of diabetic foot ulceration will reduce the number of feet proceeding to infection and necrosis, and thus reduce the number of major amputations in diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Similar content being viewed by others

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Reiber GE. Epidemiology of foot ulcers and amputations in the diabetic foot. In: Bowker JH, Pfeifer MA, editors. Levin and O’Neal’s the diabetic foot. 6th ed. St Louis: Mosby, 2001: 13–32

    Google Scholar 

  2. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990 May; 13(5): 513–21s

    Article  PubMed  CAS  Google Scholar 

  3. Bakker K, Foster AVM, van Houtum WH, et al., editors. Diabetes and foot care: time to act. Brussels: International Diabetes Federation/International Working Group of the Diabetic Foot, 2005

  4. Driver VR, Madsen J, Goodman RA. Reducing amputation rates in patients with diabetes at a military medical center: the limb preservation service model. Diabetes Care 2005 Feb; 28(2): 248–53

    Article  PubMed  Google Scholar 

  5. Edmonds M, Foster AVM. Reduction of major amputations in the diabetic ischemic foot: a strategy to ‘take control’ with conservative care as well as revascularisation. Vasa 2001; 58 Suppl.: 6–14

    Article  Google Scholar 

  6. Rith-Najarian S, Branchaud C, Beaulieu O, et al. Reducing lower-extremity amputations due to diabetes. J Fam Pract 1998; 47: 127–32

    PubMed  CAS  Google Scholar 

  7. Rith-Najarian S, Gohdes D. Preventing amputations among patients with diabetes on dialysis. Diabetes Care 2000; 23: 1445–6

    Article  PubMed  CAS  Google Scholar 

  8. van Houtum WH, Rauwerda JA, Ruwaard D, et al. Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991–2000. Diabetes Care 2004; 27: 1042–6

    Article  PubMed  Google Scholar 

  9. Mason J, O’Keeffe C, Mclntosh A, et al. A systematic review of foot ulcer in patients with Type 2 diabetes: I. prevention. Diabet Med 1999; 16: 801–12

    Article  CAS  Google Scholar 

  10. Mason JM, O’Keefe C, Mclntosh A, et al. A systematic review of foot ulcer in patients with Type 2 diabetes: II. treatment. Diabet Med 1999; 16: 889–909

    Article  CAS  Google Scholar 

  11. Hunt D, Gerstein H. Foot ulcers in diabetes. Clin Evid 2001; 5: 397–402

    Google Scholar 

  12. Eldor R, Raz I, Ben Yehuda A, et al. New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies. Diabet Med 2004 Nov; 21(11): 1161–73

    Article  PubMed  CAS  Google Scholar 

  13. Wraight PR, Lawrence SM, Campbell DA, et al. Creation of a multidisciplinary, evidence based, clinical guideline for the assessment, investigation and management of acute diabetes related foot complications. Diabet Med 2005 Feb; 22(2): 127–36

    Article  PubMed  CAS  Google Scholar 

  14. Hutchinson A, Mclntosh A, Feder G, et al. Clinical guidelines and evidence review for type 2 diabetes: prevention and management of foot problems. London: Royal College of General Practitioners, 2000 Apr

    Google Scholar 

  15. Pinzur MS, Slovenkai MP, Trepman E. Guidelines for diabetic foot care. Foot Ankle Int 1999; 20: 695–702

    PubMed  CAS  Google Scholar 

  16. Frykberg RG, Armstrong DG, Giurini J, et al. Diabetic foot disorders: a clinical practice guideline. J Foot Ankle Surg 2000; 39 (5 Suppl.): S1–60

    PubMed  CAS  Google Scholar 

  17. International Consensus on the Diabetic Foot 1999 by The International Working Group on the Diabetic Foot [online]. Available from URL: http://www.diabetic-foot-consensus.com/ [Accessed 2006 8 May]

  18. The International Working Group on the Diabetic Foot. Practical guidelines on the management and the prevention of the diabetic foot [online]. Available from URL: http://www.diabetic-foot-consensus.com/concensus/guide-linesindex.htm [Accessed 2006 8 May]

  19. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis; Epub 2004 Sep 1039(7): 885–910

    Article  Google Scholar 

  20. Reiber GE, Raugi GJ. Preventing foot ulcers and amputations in diabetes. Lancet 2005; 366(9498): 1676–7

    Article  PubMed  Google Scholar 

  21. Edmonds M, Foster AVM, Sanders LJ. A practical manual of diabetic foot care. Oxford: Blackwell Science, 2004

    Book  Google Scholar 

  22. Rith-Najarian SJ, Stolusky T, Godhes DM. Identifying diabetic patients at risk for lower extremity amputation in a primary healthcare setting. Diabetes Care 1992; 15: 1386–9

    Article  PubMed  CAS  Google Scholar 

  23. Abbott CA, Vileikyte L, Williamson S, et al. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 1998 Jul; 21(7): 1071–5

    Article  PubMed  CAS  Google Scholar 

  24. Miranda-Palma B, Sosenko JM, Bowker JH, et al. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Diabetes Res Clin Pract 2005 Oct; 70(1): 8–12

    Article  PubMed  CAS  Google Scholar 

  25. McGee SR, Boyko EJ. Physical examination and chronic lower-extremity ischemia: a critical review. Arch Intern Med 1998 Jun 22; 158(12): 1357–64

    Article  PubMed  CAS  Google Scholar 

  26. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003 Dec; 26(12): 3333–41

    Article  Google Scholar 

  27. Faglia E, Caravaggi C, Marchetti R, et al. SCAR (Screening for ARteriopathy) Study Group. Screening for peripheral arterial disease by means of the ankle-brachial index in newly diagnosed Type 2 diabetic patients. Diabet Med 2005 Oct; 22(10): 1310–4

    CAS  Google Scholar 

  28. Sanders LJ, Frykberg RG. Charcot neuroarthropathy of the foot. In: Bowker JH, Pfeifer MA, editors. Levin and O’Neal’s the diabetic foot. 6th ed. St Louis: Mosby, 2000: 467–482

    Google Scholar 

  29. Jude EB, Selby PL, Burgess J, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 2001 Nov; 44(11): 2032–7

    Article  PubMed  CAS  Google Scholar 

  30. McCabe CJ, Stevenson RC, Dolan AM. Evaluation of a diabetic foot screening and protection programme. Diabet Med 1998; 15: 80–4

    Article  PubMed  CAS  Google Scholar 

  31. McGill M, Molyneaux L, Yue DK. Which diabetic patients should receive podiatry care?. An objective analysis. Intern Med J 2005 Aug; 35(8): 451–6

    CAS  Google Scholar 

  32. Valk GD, Kriegsman DMW, Assendelft WJJ. Patient education for preventing diabetic foot ulceration (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 3. Oxford: Update Software, 2003

  33. Malone JM, Snyder M, Anderson G, et al. Prevention of amputation by diabetic education. Am J Surg 1989; 158: 520–4

    Article  PubMed  CAS  Google Scholar 

  34. Colagiuri S, Marsden L, Naidu V, et al. The use of orthotic devices to correct plantar callus in people with diabetes. Diabetes Res Clin Prac 1995; 28: 29–34

    Article  CAS  Google Scholar 

  35. Maciejewski ML, Reiber GL, Smith DG, et al. Effectiveness of diabetic therapeutic footwear in preventing reulceration. Diabetes Care 2004; 27: 1774–82

    Article  PubMed  Google Scholar 

  36. Uccioli L, Aldeghi A, Faglia E, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995; 18: 1376–8

    Article  PubMed  CAS  Google Scholar 

  37. Reiber GE, Smith DG, Wallace C, et al. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial. JAMA 2002; 287(19): 2552–8

    Article  PubMed  Google Scholar 

  38. Boulton AJ, Jude EB. Therapeutic footwear in diabetes: the good, the bad, and the ugly? Diabetes Care 2004 Jul; 27(7): 1832–3

    Article  PubMed  Google Scholar 

  39. Peters EJG, Lavery LA. Effectiveness of the diabetic foot risk classification system of the International working group on the diabetic foot. Diabetes Care 2001; 24: 1442–7

    Article  PubMed  CAS  Google Scholar 

  40. Boulton AJ. The diabetic foot: from art to science: the 18th Camillo Golgi lecture. Diabetologia; Epub 2004 Jul 2847(8): 1343–53

    Google Scholar 

  41. Nabuurs-Franssen MH, Sleegers R, Huijberts MS, et al. Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care 2005 Feb; 28(2): 243–7

    Article  PubMed  Google Scholar 

  42. Nabuurs-Franssen MH, Huijberts MS, Sleegers R, et al. Casting of recurrent diabetic foot ulcers: effective and safe? Diabetes Care 2005 Jun; 28(6): 1493–4

    Article  PubMed  Google Scholar 

  43. Caravaggi C, Faglia E, De Giglio R, et al. Effectiveness and safety of a non-removable fibreglass oo-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers: a randomised study. Diabetes Care 2000; 23: 1746–51

    Article  PubMed  CAS  Google Scholar 

  44. Katz IA, Harlan A, Miranda-Palma B, et al. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 2005; 28(3): 555–9

    Article  PubMed  Google Scholar 

  45. Armstrong DG, Nguyen HC, Lavery LA, et al. Off loading the diabetic foot wound. Diabetes Care 2001; 24: 1019–22

    Article  PubMed  CAS  Google Scholar 

  46. Edmonds ME, Foster AVM. Managing the diabetic foot. Oxford: Blackwell Science, 2005

    Book  Google Scholar 

  47. Steed DL. Foundations of good ulcer care. Am J Surg 1998; 176 Suppl 2a: 20S–5S

    Article  PubMed  CAS  Google Scholar 

  48. Wolff H, Hansson C. Larval therapy: an effective method of ulcer debridement. Clin Exp Dermatol 2003 Mar; 28(2): 134–7

    Article  PubMed  CAS  Google Scholar 

  49. Rayman A, Stansfield G, Woollard T, et al. Use of larvae in the treatment of the diabetic necrotic foot. Diabetic Foot 1998; 1: 7–13

    Google Scholar 

  50. Armstrong DG, Salas P, Short B, et al. Maggot therapy in “lower-extremity hospice” wound care: fewer amputations and more antibiotic-free days. J Am Podiatr Med Assoc 2005 May–Jun; 95(3): 254–7

    PubMed  Google Scholar 

  51. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005 Nov 12; 366(9498): 1736–43

    Article  PubMed  Google Scholar 

  52. Hilton JR, Williams DT, Beuker B, et al. Wound dressings in diabetic foot disease. Clin Infect Dis 2004; 39 Suppl. 2: S100–3

    Article  PubMed  Google Scholar 

  53. Falanga V, Sabolinski ML. Prognostic factors for healing of venous and diabetic ulcers. Wounds 2000; 12: 42A-6A

    Google Scholar 

  54. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet derived growth factor: BB (Becaplermin) in patients with non healing diabetic ulcers. A phase III, randomized, placebo-controlled, double-blind study. Diabetes Care 1998; 21: 822–7

    CAS  Google Scholar 

  55. Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs 1997; 21: 1203–10

    Article  PubMed  CAS  Google Scholar 

  56. Marston WA, Hanft J, Norwood P, et al. Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003 Jun; 26(6): 1701–5

    Google Scholar 

  57. Veves A, Falanga V, Armstrong DG, et al. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001 Feb; 24(2): 290–5

    Article  PubMed  CAS  Google Scholar 

  58. Edmonds M, Bates M, Doxford M, et al. New treatments in ulcer healing and wound infection. Diabetes/Metabolism Research and Reviews. Vol 2000; 16 Suppl. 1: S51–4

    CAS  Google Scholar 

  59. Badiavas EV, Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003; 139: 510–6

    Article  PubMed  Google Scholar 

  60. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 2002 Jul; 137(7): 822–7

    Article  PubMed  CAS  Google Scholar 

  61. Armstrong DG, Lavery LA, Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005 Nov 12; 366(9498): 1704–10

    Article  PubMed  Google Scholar 

  62. Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study. Diabetes Care 1996 Dec; 19(12): 1338–43

    Article  PubMed  CAS  Google Scholar 

  63. Wunderlich RP, Peters EJ, Lavery LA. Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot. Diabetes Care Oct 2000; 23(10): 1551–5

    Article  CAS  Google Scholar 

  64. Edmonds M, Foster A. The use of antibiotics in the diabetic foot. Am J Surg 2004 May; 187(5A): 25S–8S

    Article  PubMed  CAS  Google Scholar 

  65. Cavanagh PR, Lipsky BA, Bradbury AW, et al. Treatment for diabetic foot ulcers. Lancet 2005 Nov 12; 366(9498): 1725–35

    Article  PubMed  Google Scholar 

  66. Rayman G, Rayman A, Baker NR, et al. Sustained silver-releasing dressing in the treatment of diabetic foot ulcers. Br J Nurs 2005 Jan 27–Feb 9; 14(2): 109–14

    PubMed  CAS  Google Scholar 

  67. Chantelau E, Tanudjaja T, Altenhofer F, et al. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial. Diabet Med 1996; 13: 156–9

    Article  PubMed  CAS  Google Scholar 

  68. Edmonds ME, Walters H. Angioplasty and the diabetic foot. Vasc Med Rev 1995; 6: 205–14

    Google Scholar 

  69. Sigala F, Menenakos CH, Sigalas P, et al. Transluminal angioplasty of isolated crural arterial lesions in diabetics with critical limb ischemia. Vasa 2005 Aug; 34(3): 186–91

    Article  PubMed  CAS  Google Scholar 

  70. Eneroth M, Apelqvist J, Stenstrom A. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int 1997; 18: 716–22

    PubMed  CAS  Google Scholar 

  71. Morrison WB, Schweitzer ME, Batte WG, et al. Osteomyelitis of the foot: relative importance of primary and secondary MR imaging signs. Radiology 1998 Jun; 207(3): 625–32

    PubMed  CAS  Google Scholar 

  72. Grayson ML, Gibbons GW, Balogh K, et al. Probing to bone in infected pedal ulcers: a clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995; 273: 721–3

    Article  PubMed  CAS  Google Scholar 

  73. Tentolouris N, Petrikkos G, Vallianou N, et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. N Clin Microbiol Infect 2006 Feb; 12(2): 186–9

    Article  CAS  Google Scholar 

  74. Pellizzer G, Strazzabosco M, Presi S, et al. Deep tissue biopsy vs superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med 2001; 18: 822–7

    Article  PubMed  CAS  Google Scholar 

  75. Slater RA, Lazarovitch T, Boldur I, et al. Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone. Diabet Med 2004 Jul; 21(7): 705–9

    Article  PubMed  CAS  Google Scholar 

  76. Senneville E, Melliez H, Beltrand E, et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis; Epub 2005 Nov 2142(1): 57–62

    Google Scholar 

  77. Lipsky BA, Armstrong DG, Citron DM, et al. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 2005 Nov 12; 366(9498): 1695–703

    Article  PubMed  CAS  Google Scholar 

  78. Harkless L, Boghossian J, Pollak R, et al. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. Surg Infect (Larchmt) 2005 Spring; 6(1): 27–40

    Article  Google Scholar 

  79. Clay PG, Graham MR, Lindsey CC, et al. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with every 6 hours as empiric treatment for diabetic lower-extremity infections in older males. Am J Geriatr Pharmacother 2004 Sep; 2(3): 181–9

    Article  PubMed  CAS  Google Scholar 

  80. Venkatesan P, Lawn S, Macfarlane RM, et al. Conservative management of osteomyelitis in the feet of diabetic patients. Diabet Med 1997; 14: 487–90

    Article  PubMed  CAS  Google Scholar 

  81. Lioupis C. The role of distal arterial reconstruction in patients with diabetic foot ischemia. Int J Low Extrem Wounds 2005 Mar; 4(1): 45–9

    Article  PubMed  Google Scholar 

  82. McArthur CS, Sheahan MG, Pomposelli FB, et al. Infrainguinal revascularization after renal transplantation. J Vasc Surg 2003; 37(6): 1181–5

    Article  PubMed  Google Scholar 

  83. Ramdev P, Rayan SS, Sheahan M, et al. A decade experience with infrainguinal revascularization in a dialysis-dependent patient population. J Vasc Surg 2002; 36(5): 969–74

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The author received no funding in the preparation of this manuscript. Dr Edmonds is a member of the Scientific Advisory Boards of KCI and Ark Therapeutics.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Edmonds.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edmonds, M. Diabetic Foot Ulcers. Drugs 66, 913–929 (2006). https://doi.org/10.2165/00003495-200666070-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200666070-00003

Keywords

Navigation